Exercise and GLP-1 RA on Insulin Secretion

• Status: Recruiting
• Trial end date: 2022-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the effect of endurance exercise on insulin secretory capacity, alone or in addition to treatment with the glucagon-like-peptide receptor agonist semaglutide, in patients with type 2 diabetes.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Copenhagen

Criteria

Inclusion Criteria:

• Diagnosed with type 2 diabetes

• BMI 28-35

• Moderately preserved insulin secretory capacity (determined by glucagon test)

Exclusion Criteria:

• Insulin treatment

• Hypertension grade 3

• Heart disease

• Medical history with pancreatitis

• Diagnosed with neuropathy

• Excessive alcohol consumption

• Any condition that would interfere with the protocol.